Executive Search: Biotech, Pharma, MedTech and related nonprofits. We help drive drug development and build mission driven teams. Rare & common disorders.
Excited to kick off our #CAMP4Fireside Series to highlight the people behind CAMP4. Hear from our CEO, Josh Mandel-Brehm, as he shares a glimpse into what’s ahead. Watch the video, and learn more about our mission here: https://t.co/oHsGTjJJRo
Biotech startups offer a 'resilience dividend.' Even if a venture fails, the experience of building from scratch is resume gold. These unique skills make it a low-risk career move in the long run.
#BiotechCareers#Resilience#DenvillePartners#Leadership
Would you hire you ??
Tough conversations in full transparency:
We are extremely fortunate to have the opportunity to work on very senior level high impact positions.
We are hired to ensure that our client hires the best candidate possible.
Since we are so proactive in our approach, we often end up speaking with multiple highly qualified passionate human beings.
Some or are more qualified than others, and some are better fit than others.
If we are doing our work right, we have to make some very challenging decisions about who and who we don’t present
Telling someone that we have decided not to present their credentials can be a challenging conversation. After all, we are only a search firm, right?
There is typically one of two reactions.
I will let you guess what they are.
Some of these folks become clients for life. The others…….
However, I have found that one question often helps us level set in that question is:
If you were the hiring manager for this position, would you hire you?
Be honest, would you?
Bruce Booth on the successes and failures that have shaped the biotech industry — reflecting on past breakthroughs, changes in the funding landscape, and promising drug modalities now in development https://t.co/Ru97JoSsGp
https://t.co/ukIbdSNZ3E
The mission is pure: support women at each and every step in their career.
While biotech does better than most industries as it relates to equality and diversity, any gap is too big.
Please reach out to our team to learn more.
Denville Partners is deeply honored to support Women in Bio (WIB) as they search for a new #CEO
We look forward to partnering with the board to find a mission driven leader
#WIB#equality#biotech
Inquiries and questions welcome.
The mission is pure: support women at each and every step in their career.
While biotech does better than most industries as it relates to equality and diversity, any gap is too big.
Please reach out to our team to learn more.
Denville Partners is deeply honored to support Women in Bio (WIB) as they search for a new #CEO
We look forward to partnering with the board to find a mission driven leader
#WIB#equality#biotech
Inquiries and questions welcome.
Registration is now open for the ULF Scientific Symposium & Family Conference June 25-27 at Hilton Chicago/Oak Brook Hills Resort & Conference Center, Oak Brook, IL 60523. Take advantage of discounted early bird rates by registering by 3/13/26. Register https://t.co/iCsW3okfwV
Kicking off our new Scientific Shorts series: a new series designed to break down big ideas in endocrinology. First up: What is the endocrine system? Watch Crinetics Chief Endocrinologist, Alan Krasner, M.D., explain how the endocrine system plays a critical role in everyday health and helps keep the body in balance.
Our potentially disease modifying therapy for myotonic dystrophy type 1, PGN-EDODM1, is being evaluated in the phase 2 FREEDOM2-DM1 clinical study. Learn more in the video below.
Biotech leaders are thinking global, not just local. 🌍 In the race for innovation, top talent can be anywhere: and the best are removing borders to build world-class teams. Where you work matters less than what you bring. #Biotech#Talent#Leadership
AI + digital fluency is now core for rare disease leaders: not just using tech, but shaping it: asking better data questions, setting trust, keeping patients at the center. The winning formula: science + systems + empathy. #RareDisease#AI#DigitalHealth#Biotech
Rare disease breakthroughs go far beyond rare: unlocking platforms for oncology, neuro & immunology. Now’s the time for visionary leaders to translate edge-case science into industry-wide impact. #RareDisease#Biotech#Leadership
Rare disease awareness is evolving; think art, music, AR. Clarity and creativity move hearts and build trust faster than any brochure. For leaders: stories and empathy are the new force multipliers. #RareDisease#Biotech#Healthcare
2026 is rare disease biotech’s “prove it” year. Winning leaders go beyond promise: delivering results with focus, urgency, discipline, and execution across teams. Building for approval + access? Let’s connect. #RareDisease#Biotech
Patient advocates aren’t just “stakeholders”: they’re co-leaders in rare disease R&D. When the patient voice shapes studies, teams move faster and with greater trust. Leadership means listening. #RareDisease#ClinicalTrials